OMER - Omeros Corporation
NEXT EARNINGS:
Mar 3, 2026
(in 6 days)
EPS Est: $-0.57
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$40.00
DETAILS
HIGH:
$40.00
LOW:
$40.00
MEDIAN:
$40.00
CONSENSUS:
$40.00
UPSIDE:
246.32%
Market Cap:
818.90M
Volume:
864,686
Avg Volume:
2,413,473
52 Week Range:
2.95-17.65
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.45
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
202
IPO Date:
2009-10-08
EPS (TTM):
-2.70
P/E Ratio:
-3.67
Revenue (TTM):
N/A
Total Assets:
277.08M
Total Debt:
207.02M
Cash & Equiv:
3.40M
Rev Growth (5Y):
-100.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-80.0%
Debt/Equity:
-1.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $-0.19 | $-0.58 | +67.2% | — | — | — |
| 2025-08-14 | $-0.53 | $-0.55 | +3.6% | — | $312500 | — |
| 2025-05-15 | $-0.65 | $-0.57 | -14.0% | — | $416670 | — |
| 2025-03-31 | $-0.63 | $-0.78 | +19.2% | $412000 | — | — |
| 2024-11-13 | $-0.64 | $-0.70 | +8.6% | — | — | — |
| 2024-08-07 | $-1.12 | $-1.14 | +1.8% | — | — | — |
| 2024-05-15 | $-0.74 | $-0.58 | -27.6% | — | — | — |
| 2024-04-01 | $-0.63 | $-0.56 | -12.5% | $1.4M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 111.81M | 29.87M | 64.83M | 41.62M | 13.51M | 539,000 | 1.60M |
| Net Income | (156.81M) | (117.81M) | 47.42M | (111.41M) | (138.06M) | (84.49M) | (126.76M) | (53.48M) | (66.75M) | (75.10M) | (73.67M) | (39.80M) |
| EPS | -2.70 | -1.88 | 0.46 | 3.12 | -2.41 | -2.16 | -2.61 | -1.17 | -1.65 | -2.00 | -2.22 | -1.39 |
| Total Assets | 277.08M | 378.27M | 590.97M | 419.27M | 181.04M | 136.97M | 95.94M | 116.33M | 67.28M | 48.99M | 11.09M | 16.54M |
| Total Debt | 207.02M | 361.58M | 342.02M | 347.84M | 268.84M | 194.03M | 151.45M | 84.61M | 79.71M | 49.84M | 32.71M | 20.50M |
| Cash & Equivalents | 3.40M | 7.11M | 11.01M | 100.81M | 10.50M | 3.08M | 5.86M | 3.39M | 2.22M | 1.36M | 354,000 | 1.38M |
| Operating Cash Flow | (148.80M) | 74.73M | (86.48M) | (109.72M) | (100.09M) | (60.07M) | (103.74M) | (36.23M) | (51.50M) | (65.21M) | (58.04M) | (29.70M) |
| Free Cash Flow | (148.97M) | 74.30M | (86.60M) | (110.00M) | (100.37M) | (60.41M) | (104.30M) | (36.58M) | (51.63M) | (65.45M) | (58.07M) | (29.90M) |
| FCF per Share | -2.56 | 1.18 | -1.38 | -1.76 | -1.76 | -1.22 | -2.15 | -0.80 | -1.28 | -1.74 | -1.75 | -1.05 |
| Book Value | (182.61M) | (24.98M) | 85.68M | 23.78M | (120.75M) | (109.02M) | 650.12M | (2.81M) | (37.45M) | (26.23M) | (42.65M) | (18.38M) |
| Cash & ST Investments | 90.13M | 171.85M | 194.92M | 157.27M | 134.95M | 60.79M | 60.50M | 83.75M | 45.33M | 28.26M | 6.89M | 14.10M |
| ROC Equity | N/A | N/A | 0.55 | -4.69 | N/A | N/A | -0.19 | N/A | N/A | N/A | N/A | N/A |